Clinical trial
Randomized, Single Dose, 2-Way Crossover, Relative Bioavailability Study of Desloratadine Orally Disintegrating Tablet Fasting Conditions
NCT01506050 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Single Dose, 2-Way Crossover, Relative Bioavailability Study of Desloratadine Orally Disintegrating Tablet Fasting Conditions
- Lead sponsor
- Dr. Reddy's Laboratories Limited
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- February 28, 2006
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy